Psychosis

In an Unexpected Role, Blood Pressure-Regulating ACE Proteins May Be Valuable as Objective Biomarkers for Schizophrenia and Psychotic Disorders
In new research, a team led by BBRF grantees provides a vivid example of how the longstanding effort to identify risk genes for psychiatric illness can pay off in tangible ways, informing research on… Read More
Imaging Suggests Disruptions in Early Schizophrenia in How Neurons and Astroglia Coordinate to Balance Excitation and Inhibition
The continuing search for more effective schizophrenia treatments is directly related to efforts by researchers to more precisely understand mechanisms underlying major symptoms such as psychosis and… Read More
Ketogenic Diet, in a First Randomized Trial, Correlates With Symptom Improvement in Schizophrenia & Bipolar Disorder With Psychosis
A team led by BBRF grantees and Scientific Council members has reported the first-ever randomized, controlled trial to assess the effects of a ketogenic diet on psychiatric symptoms, metabolism, and… Read More
In a First Episode of Psychosis (FEP), Distinct Symptoms, Cognition, and EEG Measures Seen in Cannabis Users vs. Non-Users
A team led by a two-time BBRF grantee has published research suggesting the possibility that cannabis use in some individuals may be associated with a distinct subtype of first-episode psychosis (FEP… Read More
In Youths at High Risk of Psychosis, a Marker in White Blood Cells May Be an Important Indicator of Response to Therapy
Researchers have reported new evidence bearing on their multi-year effort to identify clinically useful markers of high risk for the onset of psychosis in young people. Read More